Physician profile
Robert S Rice
NPI 1730166182
$11,041.29
in general payments reported to CMS, 2019-2025
32 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $3,210 · 2021: $4,117 · 2022: $164 · 2023: $2,140 · 2024: $672 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903 · Travel and Lodging: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.92 |
| Travel and Lodging | $1,108.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,102.59 | 2020-2023 | |
| Active Medical, LLC | $1,876.86 | 2019-2025 | |
| Smith+Nephew, INC. | $292.47 | 2019-2024 | Lens 4k, Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $202.16 | 2023-2024 | |
| Vericel Corporation | $171.14 | 2020-2024 | Maci |
| Globus Medical, INC. | $148.03 | 2022-2025 | Anthem, Distal Radius II, Clavicular Fracture Fixation |
| Miach Orthopaedics, INC. | $144.57 | 2024 | |
| Ferring Pharmaceuticals INC. | $141.40 | 2019-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $124.50 | 2019-2022 | |
| Bioventus LLC | $101.84 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $93.94 | 2019-2023 | |
| Anika Therapeutics, INC. | $91.87 | 2024-2025 | X-Twist, Integrity, Tactoset |
| Solventum Corporation | $67.76 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Vertex Pharmaceuticals Incorporated | $51.77 | 2025 | |
| Stryker Corporation | $43.54 | 2024 | Iconix, Alphavent |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $41.41 | 2019 | |
| Cerapedics INC. | $39.39 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Acera Surgical, INC. | $34.61 | 2023 | Restrata Wound Matrix |
| Fidia Pharma USA INC. | $30.70 | 2019-2020 | |
| Averitas Pharma INC. | $29.38 | 2024 | Qutenza |
| Orthofix Medical, INC. | $26.17 | 2023 | Physio-Stim |
| Horizon Therapeutics Plc | $21.81 | 2023 | Krystexxa |
| Nalu Medical, INC. | $21.04 | 2022 | |
| Derma Sciences, INC. | $20.07 | 2019 | |
| Urgo Medical North America, LLC | $18.65 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Aesculap, INC. | $17.97 | 2023 | Aesculap |
| Kci USA, INC. | $16.38 | 2023 | Prevena |
| Allergan, INC. | $15.63 | 2020 | |
| Biocomposites INC | $14.96 | 2024 | |
| Radius Health, INC. | $14.23 | 2021 | |
| Acell, INC. | $13.37 | 2020 | |
| Davol INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.